ACAD
32.77
+0.39
+1.20%
AEMD
5.83
-0.15
-2.51%
APRI
0.38
0.00
-0.1053%
ARNA
1.715
-0.035
-2.000%
ATEC
0.357
+0.011
+3.3034%
CNAT
2.11
-0.05
-2.31%
CRXM
0.155
-0.002
-1.022%
CYTX
2.11
+0.02
+0.96%
DXCM
79.27
+0.27
+0.34%
GNMK
8.7
+0.03
+0.35%
HALO
8.702
+0.272
+3.2218%
ILMN
138.94
+1.36
+0.99%
INNV
0.214
-0.003
-1.382%
INO
9.28
-0.15
-1.59%
ISCO
1.99
-0.01
-0.50%
ISIS
57.56
0.00
0.00%
LGND
119.73
-1.69
-1.39%
LPTN
2.18
-0.02
-0.9045%
MBVX
0.55
0.00
0.00%
MEIP
1.37
+0.02
+1.48%
MNOV
7.54
+0.2
+2.72%
MRTX
5.47
-0.02
-0.36%
MSTX
0.467
+0.007
+1.5652%
NBIX
46.04
+0.65
+1.43%
NUVA
59.45
+0.18
+0.30%
ONCS
1.67
-0.01
-0.60%
ONVO
3.71
+0.07
+1.92%
OREX
0.438
-0.003
-0.7026%
OTIC
15.72
-0.03
-0.19%
QDEL
17.8
+0.16
+0.91%
RCPT
231.96
0.00
0.00%
RGLS
2.85
-0.02
-0.70%
RMD
62.94
+0.91
+1.47%
SPHS
2.123
+0.123
+6.1450%
SRNE
5.67
-0.28
-4.71%
TROV
4.53
0.00
0.00%
VICL
4.57
+0.04
+0.88%
VOLC
18
0.00
0.00%
ZGNX
8.1
+0.01
+0.12%
ACAD
32.77
+0.39
+1.20%
AEMD
5.83
-0.15
-2.51%
APRI
0.38
0.00
-0.1053%
ARNA
1.715
-0.035
-2.000%
ATEC
0.357
+0.011
+3.3034%
CNAT
2.11
-0.05
-2.31%
CRXM
0.155
-0.002
-1.022%
CYTX
2.11
+0.02
+0.96%
DXCM
79.27
+0.27
+0.34%
GNMK
8.7
+0.03
+0.35%
HALO
8.702
+0.272
+3.2218%
ILMN
138.94
+1.36
+0.99%
INNV
0.214
-0.003
-1.382%
INO
9.28
-0.15
-1.59%
ISCO
1.99
-0.01
-0.50%
ISIS
57.56
0.00
0.00%
LGND
119.73
-1.69
-1.39%
LPTN
2.18
-0.02
-0.9045%
MBVX
0.55
0.00
0.00%
MEIP
1.37
+0.02
+1.48%
MNOV
7.54
+0.2
+2.72%
MRTX
5.47
-0.02
-0.36%
MSTX
0.467
+0.007
+1.5652%
NBIX
46.04
+0.65
+1.43%
NUVA
59.45
+0.18
+0.30%
ONCS
1.67
-0.01
-0.60%
ONVO
3.71
+0.07
+1.92%
OREX
0.438
-0.003
-0.7026%
OTIC
15.72
-0.03
-0.19%
QDEL
17.8
+0.16
+0.91%
RCPT
231.96
0.00
0.00%
RGLS
2.85
-0.02
-0.70%
RMD
62.94
+0.91
+1.47%
SPHS
2.123
+0.123
+6.1450%
SRNE
5.67
-0.28
-4.71%
TROV
4.53
0.00
0.00%
VICL
4.57
+0.04
+0.88%
VOLC
18
0.00
0.00%
ZGNX
8.1
+0.01
+0.12%
Home » Archive by Category

Diagnostics

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

The Future of Personal Genetic Testing and Diagnostics with Pathway Genomics

August 26, 2011 – 9:57 am

The Pathway Genomics business model is based on bridging a gap in personalized medicine.  As Ed MacBean, their VP of Product Development, explained at SDBN’s August 16th event, in a nutshell they connect clients through …

SDBN August 16th 2011 Event Featuring Pathway Genomics

July 29, 2011 – 9:41 am

We polled you late last year about events you’d like us to have in 2011, and diagnostics was one of the top items on the list. In San Diego, we have a great atmosphere for …